A citation-based method for searching scientific literature

Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Louis Monnier, Anne Wojtusciszyn, Nicolas Molinari, Claude Colette, Eric Renard, David Owens. Diabetes Care 2020
Times Cited: 4






Login to export Results
Don't have an account? Register here

List of co-cited articles
23 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
356
4
100

Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
101
3
75

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
70
2
50

Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial.
Chang-Sheng Sheng, Jingyan Tian, Ya Miao, Yi Cheng, Yulin Yang, Peter D Reaven, Zachary T Bloomgarden, Guang Ning. Diabetes Care 2020
10
2
50

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
91
2
50

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
13858
2
50

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
1335
2
50

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
610
2
50

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
Richard M Bergenstal, Roy W Beck, Kelly L Close, George Grunberger, David B Sacks, Aaron Kowalski, Adam S Brown, Lutz Heinemann, Grazia Aleppo, Donna B Ryan,[...]. Diabetes Care 2018
100
2
50

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
462
2
50

6. Glycemic Targets: Standards of Medical Care in Diabetes-2020.
. Diabetes Care 2020
156
2
50

Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maria Ida Maiorino, Simona Signoriello, Antonietta Maio, Paolo Chiodini, Giuseppe Bellastella, Lorenzo Scappaticcio, Miriam Longo, Dario Giugliano, Katherine Esposito. Diabetes Care 2020
15
2
50

Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
Lutz Heinemann, Guido Freckmann, Dominic Ehrmann, Gabriele Faber-Heinemann, Stefania Guerra, Delia Waldenmaier, Norbert Hermanns. Lancet 2018
129
2
50

The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.
Roy W Beck, Crystal G Connor, Deborah M Mullen, David M Wesley, Richard M Bergenstal. Diabetes Care 2017
112
2
50

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
333
2
50

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Robert A Vigersky, Chantal McMahon. Diabetes Technol Ther 2019
67
2
50

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.
Grazia Aleppo, Katrina J Ruedy, Tonya D Riddlesworth, Davida F Kruger, Anne L Peters, Irl Hirsch, Richard M Bergenstal, Elena Toschi, Andrew J Ahmann, Viral N Shah,[...]. Diabetes Care 2017
100
2
50

Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon Kim. Diabetes Metab J 2015
119
2
50

Hypo- and hyperglycemia in relation to the mean, standard deviation, coefficient of variation, and nature of the glucose distribution.
David Rodbard. Diabetes Technol Ther 2012
40
2
50

Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes.
Boris Kovatchev, Claudio Cobelli. Diabetes Care 2016
93
2
50

Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
Suresh Rama Chandran, Wei Lin Tay, Weng Kit Lye, Lee Ling Lim, Jeyakantha Ratnasingam, Alexander Tong Boon Tan, Daphne S L Gardner. Diabetes Technol Ther 2018
28
2
50

Clinical interpretation of indices of quality of glycemic control and glycemic variability.
David Rodbard. Postgrad Med 2011
80
2
50

Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.
Tonya D Riddlesworth, Roy W Beck, Robin L Gal, Crystal G Connor, Richard M Bergenstal, Sooji Lee, Steven M Willi. Diabetes Technol Ther 2018
57
2
50

Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.
. Diabetes Care 2016
213
1
25

Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
Ionut Bebu, David Schade, Barbara Braffett, Mikhail Kosiborod, Maria Lopes-Virella, Elsayed Z Soliman, William H Herman, David A Bluemke, Amisha Wallia, Trevor Orchard,[...]. Diabetes Care 2020
7
1
25

The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.
Louis Monnier, Claude Colette, Gareth J Dunseath, David R Owens. Diabetes Care 2007
260
1
25

Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange.
Gina Agiostratidou, Henry Anhalt, Dana Ball, Lawrence Blonde, Evgenia Gourgari, Karen N Harriman, Aaron J Kowalski, Paul Madden, Alicia H McAuliffe-Fogarty, Molly McElwee-Malloy,[...]. Diabetes Care 2017
124
1
25

Positioning time in range in diabetes management.
Andrew Advani. Diabetologia 2020
12
1
25

Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
Irl B Hirsch. Diabetes Care 2015
109
1
25

Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia.
Philip E Cryer. Diabetes 2014
109
1
25

Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.
Louis Monnier, Claude Colette, David R Owens. Diabetes Metab Res Rev 2009
51
1
25

Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
Jan Šoupal, Lenka Petruželková, Milan Flekač, Tomáš Pelcl, Martin Matoulek, Martina Daňková, Jan Škrha, Štěpán Svačina, Martin Prázný. Diabetes Technol Ther 2016
44
1
25

Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.
. Diabetes Care 2017
248
1
25

Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial.
Stephen N Davis, William Duckworth, Nicholas Emanuele, Rodney A Hayward, Wyndy L Wiitala, Lizy Thottapurathu, Domenic J Reda, Peter D Reaven. Diabetes Care 2019
33
1
25

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.
. Diabetes Care 2005
731
1
25

Review of methods for detecting glycemic disorders.
Michael Bergman, Muhammad Abdul-Ghani, Ralph A DeFronzo, Melania Manco, Giorgio Sesti, Teresa Vanessa Fiorentino, Antonio Ceriello, Mary Rhee, Lawrence S Phillips, Stephanie Chung,[...]. Diabetes Res Clin Pract 2020
7
1
25

The pathobiology of diabetic complications: a unifying mechanism.
Michael Brownlee. Diabetes 2005
2635
1
25

A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES).
Glen H Murata, Richard M Hoffman, Jayendra H Shah, Christopher S Wendel, William C Duckworth. Arch Intern Med 2004
47
1
25

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring.
Steven V Edelman, Nicholas B Argento, Jeremy Pettus, Irl B Hirsch. Diabetes Care 2018
37
1
25

Random plasma glucose predicts the diagnosis of diabetes.
Mary K Rhee, Yuk-Lam Ho, Sridharan Raghavan, Jason L Vassy, Kelly Cho, David Gagnon, Lisa R Staimez, Christopher N Ford, Peter W F Wilson, Lawrence S Phillips. PLoS One 2019
9
1
25

Metrics for glycaemic control - from HbA1c to continuous glucose monitoring.
Boris P Kovatchev. Nat Rev Endocrinol 2017
71
1
25

Lowest Glucose Variability and Hypoglycemia Are Observed With the Combination of a GLP-1 Receptor Agonist and Basal Insulin (VARIATION Study).
Harpreet S Bajaj, Karri Venn, Chenglin Ye, Avril Patrick, Shivani Kalra, Hasnain Khandwala, Nadeem Aslam, David Twum-Barima, Ronnie Aronson. Diabetes Care 2017
27
1
25

Measurement of hemoglobin A(1c): a new twist on the path to harmony.
David B Sacks. Diabetes Care 2012
55
1
25

7. Diabetes Technology: Standards of Medical Care in Diabetes-2020.
. Diabetes Care 2020
48
1
25

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.
. Diabetes Care 2020
369
1
25

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
3969
1
25

Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
Catherine Gorst, Chun Shing Kwok, Saadia Aslam, Iain Buchan, Evangelos Kontopantelis, Phyo K Myint, Grant Heatlie, Yoon Loke, Martin K Rutter, Mamas A Mamas. Diabetes Care 2015
184
1
25

Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?
Louis Monnier, Claude Colette, Sylvie Dejager, David Owens. Diabetes Care 2013
42
1
25

Residual dysglycemia when at target HbA(1c) of 7% (53mmol/mol) in persons with type 2 diabetes.
L Monnier, C Colette, S Dejager, D Owens. Diabetes Res Clin Pract 2014
15
1
25

The application of simple metrics in the assessment of glycaemic variability.
L Monnier, C Colette, D R Owens. Diabetes Metab 2018
29
1
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.

Longstocking, LLC. © 2020
Home | About Us | FAQs | Terms & Privacy